SCHEMBL9521149

SCHEMBL9521149

CC#CC1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C(O)C[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 12/20 0.52
▸ SHBG P04278 1/20 0.52
▸ SERPINA6 P08185 1/20 0.49
▸ CYP3A4 P08684 3/20 0.43
▸ NR3C1 P04150 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ HIF1A Q16665 2/20 0.42
▸ PGR P06401 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ MEN1 O00255 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ AR P10275 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11019743 0.83 SERPINA6 (0.70) CYP19A1SHBGSERPINA6CYP3A4NR3C1
SCHEMBL4116607 0.76 CYP3A4 (0.71) CYP19A1SHBGSERPINA6CYP3A4NR3C1
SCHEMBL13752655 0.76 CYP3A4 (0.71) CYP19A1SHBGSERPINA6CYP3A4NR3C1
SCHEMBL4116602 0.76 CYP3A4 (0.71) CYP19A1SHBGSERPINA6CYP3A4NR3C1
SCHEMBL11702055 0.76 LMNA (0.54) CYP19A1SHBGSERPINA6CYP3A4NR3C1
SCHEMBL8938537 0.76 LMNA (0.54) CYP19A1SHBGSERPINA6CYP3A4NR3C1
SCHEMBL11021232 0.74 SERPINA6 (0.50) CYP19A1SHBGSERPINA6CYP3A4NR3C1
SCHEMBL11022201 0.71 SERPINA6 (0.47) CYP19A1SHBGSERPINA6CYP3A4NR3C1
SCHEMBL4751113 0.71 SERPINA6 (0.67) CYP19A1SHBGSERPINA6CYP3A4NR3C1
SCHEMBL11020224 0.70 SERPINA6 (0.62) CYP19A1SHBGSERPINA6CYP3A4NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0566566-A1 COMPOSITIONS AND METHODS FOR ALLEVIATING MENOPAUSAL SYMPTOMS. APPLIED MED RES LTD (US) 1993-10-27 — — EP disclosed
WO-1992011855-A1 COMPOSITIONS AND METHODS FOR ALLEVIATING MENOPAUSAL SYMPTOMS APPLIED MEDICAL RESEARCH, LTD. (US) 1992-07-23 — — WO disclosed
Send feedback